With these samples, we first assessed FGF23 mRNA levels by qPCR and found a 13 -fold increase in ALS muscle samples over normal control subjects (P = 0.0001; Fig. 1). This evidence concerns the gene FGF23 and amyotrophic lateral sclerosis.